Robert J Fram

3PUBLICATIONS
21CO-AUTHORS
Rheumatology and arthritisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 18, 2025
Real-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial.

Myung-Ju Ahn, Angelo Delmonte, Sharmistha Ghosh

|Jan 29, 2025
First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial.

Pasi A Jänne, Bin-Chao Wang, Byoung Chul Cho

|May 24, 2024
A phase 1 study to assess the absolute bioavailability, mass balance, pharmacokinetics, metabolism, and excretion of [14C]-mobocertinib, an oral inhibitor of EGFR exon 20 insertion mutations, in healthy participants.

Michael J Hanley, Steven Zhang, Robert Griffin

Pageof 1

Frequent Collaborators

1 joint publications

Michael J Hanley

1 joint publications

Robert Griffin

1 joint publications

Sean Xiaochun Zhu

1 joint publications

Karthik Venkatakrishnan